Gryglewski R J, Nicolaou K C
Experientia. 1978 Oct 15;34(10):1336-8. doi: 10.1007/BF01981457.
6,9-Thiaprostacyclin was used as a representative of prostacyclin analogues with the aim to design the most convenient procedure for evaluation of vasodilator, anti-platelet and other biological properties within this new group of potential anti-thrombotic agents.